New appointment at Systagenix Wound Management
This article was originally published in Scrip
Systagenix Wound Management (UK) has appointed Frank DiLazzaro president of Europe, Middle East & Africa. He has experience in the wound care sector, having played a role in the transformation of the negative pressure wound therapy business at Kinetic Concepts.
You may also be interested in...
Nearly 500 shipments of illegal and unapproved prescription drugs and combination medical devices were seized at US borders thanks to Operation Broadsword.
Sanofi follows Janssen in teaming up with HHS' BARDA to develop a COVID-19 vaccine; using technology platform of its Flublok vaccine, Sanofi expects to enter clinical trials in 1 to 1 ½ years.
Biotech licenses drug composition patents from University of Alaska Fairbanks for study in several disease states. Gilead seeks long-acting HIV therapy or prevention with broadly neutralizing antibodies discovered by Rockefeller U.